bilobalide has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anusree, SS; Nisha, VM; Priyanka, A; Raghu, KG | 1 |
| Nisha, VM; Preetha Rani, MR; Priyanka, A; Raghu, KG; Shyni, GL; Sindhu, G | 1 |
2 other study(ies) available for bilobalide and Obesity
| Article | Year |
|---|---|
Bilobalide attenuates hypoxia induced oxidative stress, inflammation, and mitochondrial dysfunctions in 3T3-L1 adipocytes via its antioxidant potential.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Antioxidants; Cell Hypoxia; Cyclopentanes; Furans; Ginkgolides; Inflammation; Mice; Mitochondria; Obesity; Oxidative Stress | 2014 |
Bilobalide abates inflammation, insulin resistance and secretion of angiogenic factors induced by hypoxia in 3T3-L1 adipocytes by controlling NF-κB and JNK activation.
Topics: Adipocytes; Anti-Inflammatory Agents; Cell Line; Cyclopentanes; Furans; Ginkgolides; Humans; Hypoxia; Inflammation; Insulin Receptor Substrate Proteins; Insulin Resistance; MAP Kinase Kinase 4; Neovascularization, Pathologic; NF-kappa B; Obesity; Signal Transduction; Transcriptional Activation | 2017 |